Target intelligence / Profile preview

High mobility group box 1 pseudogene 41 (HMGB1P41)

Target
HMGB1P41
Molecular classification
Other
01

Overview

High mobility group box 1 pseudogene 41 (HMGB1P41) is a pseudogene in Homo sapiens. Pseudogenes are genomic elements that closely resemble functional genes but contain disabling mutations or lack regulatory elements, and therefore do not produce functional proteins. HMGB1P41 shares sequence similarity with the coding gene HMGB1 but is noncoding and has no known biological function or direct disease relevance. It is not considered a therapeutic target[1][4]. As a pseudogene, HMGB1P41 is not an active protein or receptor and does not serve as a direct target for drugs or therapeutic intervention[1][4]. It is a pseudogene, which means it is not a functional gene product or a classical drug target in biomedical research or therapy. Listing it as a therapeutic target or receptor is incorrect[1][2]. As a pseudogene, HMGB1P41 falls into the "Other" molecular classification; it is not a transcription factor, receptor, enzyme, transporter, or ion channel[2][3]. It has no described roles in signal transduction, cell cycle, apoptosis, immune response, disease, or as a drug biomarker. Its parent gene, HMGB1, encodes a functional protein involved in DNA binding and chromatin organization, but HMGB1P41 itself is non-functional[1][4]. In summary, HMGB1P41 is a non-functional pseudogene, not a therapeutic target, with no clinical, biological, or mechanistic drug relevance based on current literature and gene annotation databases[1][4].

Other names
high-mobility group box 1 pseudogene 41
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 41 (HMGB1P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 41 (HMGB1P41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call